Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer.
The report details the trend, potential and market size of Cancer Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Immunotherapymarket, defines the market attractiveness level of Cancer Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Immunotherapy industry, describes the types of Cancer Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Immunotherapy market and the development prospects and opportunities of Cancer Immunotherapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Immunotherapy market in Chapter 13.
By Player:
Merck & Co Inc
Bristol-Myers Squibb
Janssen Global Services
Novartis International Ag
Seattle Genetics Inc
Amgen Inc
Printegra
Celgene Corporation
LLC
Pfizer Inc
Gristone Oncology, Inc
By Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
By End-User:
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Immunotherapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Immunotherapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Immunotherapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Immunotherapy Market Analysis and Outlook to 2022
-
7.1 Global Cancer Immunotherapy Consumption (2017-2022)
-
7.2 United States Cancer Immunotherapy Consumption (2017-2022)
-
7.3 Europe Cancer Immunotherapy Consumption (2017-2022)
-
7.4 China Cancer Immunotherapy Consumption (2017-2022)
-
7.5 Japan Cancer Immunotherapy Consumption (2017-2022)
-
7.6 India Cancer Immunotherapy Consumption (2017-2022)
-
7.7 South Korea Cancer Immunotherapy Consumption (2017-2022)
8 Region and Country-wise Cancer Immunotherapy Market Analysis and Outlook to 2028
-
8.1 Global Cancer Immunotherapy Consumption Forecast (2022-2028)
-
8.2 United States Cancer Immunotherapy Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Immunotherapy Consumption Forecast (2022-2028)
-
8.4 China Cancer Immunotherapy Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Immunotherapy Consumption Forecast (2022-2028)
-
8.6 India Cancer Immunotherapy Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Immunotherapy Consumption Forecast (2022-2028)
9 Global Cancer Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Immunotherapy Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Immunotherapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Immunotherapy Market Competitive Analysis
-
14.1 Merck & Co Inc
-
14.1.1 Merck & Co Inc Company Details
-
14.1.2 Merck & Co Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Inc Cancer Immunotherapy Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Cancer Immunotherapy Product and Service
-
14.3 Janssen Global Services
-
14.3.1 Janssen Global Services Company Details
-
14.3.2 Janssen Global Services Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Janssen Global Services Cancer Immunotherapy Product and Service
-
14.4 Novartis International Ag
-
14.4.1 Novartis International Ag Company Details
-
14.4.2 Novartis International Ag Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis International Ag Cancer Immunotherapy Product and Service
-
14.5 Seattle Genetics Inc
-
14.5.1 Seattle Genetics Inc Company Details
-
14.5.2 Seattle Genetics Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Seattle Genetics Inc Cancer Immunotherapy Product and Service
-
14.6 Amgen Inc
-
14.6.1 Amgen Inc Company Details
-
14.6.2 Amgen Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Inc Cancer Immunotherapy Product and Service
-
14.7 Printegra
-
14.7.1 Printegra Company Details
-
14.7.2 Printegra Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Printegra Cancer Immunotherapy Product and Service
-
14.8 Celgene Corporation
-
14.8.1 Celgene Corporation Company Details
-
14.8.2 Celgene Corporation Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Celgene Corporation Cancer Immunotherapy Product and Service
-
14.9 LLC
-
14.9.1 LLC Company Details
-
14.9.2 LLC Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 LLC Cancer Immunotherapy Product and Service
-
14.10 Pfizer Inc
-
14.10.1 Pfizer Inc Company Details
-
14.10.2 Pfizer Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Inc Cancer Immunotherapy Product and Service
-
14.11 Gristone Oncology, Inc
-
14.11.1 Gristone Oncology, Inc Company Details
-
14.11.2 Gristone Oncology, Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Gristone Oncology, Inc Cancer Immunotherapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Immunotherapy
-
Figure Cancer Immunotherapy Picture
-
Table Global Cancer Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Immunotherapy Consumption by Country (2017-2022)
-
Figure United States Cancer Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Cancer Immunotherapy Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Immunotherapy Product and Service
-
Table Janssen Global Services (Foundation Year, Company Profile and etc.)
-
Table Janssen Global Services Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Global Services Cancer Immunotherapy Product and Service
-
Table Novartis International Ag (Foundation Year, Company Profile and etc.)
-
Table Novartis International Ag Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International Ag Cancer Immunotherapy Product and Service
-
Table Seattle Genetics Inc (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Inc Cancer Immunotherapy Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Cancer Immunotherapy Product and Service
-
Table Printegra (Foundation Year, Company Profile and etc.)
-
Table Printegra Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Printegra Cancer Immunotherapy Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Cancer Immunotherapy Product and Service
-
Table LLC (Foundation Year, Company Profile and etc.)
-
Table LLC Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table LLC Cancer Immunotherapy Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Cancer Immunotherapy Product and Service
-
Table Gristone Oncology, Inc (Foundation Year, Company Profile and etc.)
-
Table Gristone Oncology, Inc Cancer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gristone Oncology, Inc Cancer Immunotherapy Product and Service
-
